Out the Gym 6.4.19

so I ran 2mi today in 100+ degree heat.  I’m trying to lower my BP, stop drinking, deal with relationship issues, and a new job that frankly…just isn’t me.  It doesn’t recognize work/life balance and is causing me a lot of stress.  Not what the doctor ordered.

So, it’s now day 12 on BP meds.  I still show high at times 157/97, but less frequently.  I’ve cut my drinking to sort of every 2nd day, but may have to go more military on that.

As of Sunday I will be in a kind of isolation tank for a couple weeks, and I’ll use that to kick off the cold turkey part of the package.

keeping you in the loop.


Below i’ve attached an article by Paul T. Williams  from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803745/

Time to speed up my mile times.

Relationship of Running Intensity to Hypertension, Hypercholesterolemia, and Diabetes


To estimate the independent relationships of running intensity with antihypertensive, LDL-cholesterol–lowering, and antidiabetic medication use when adjusted for running volume (km/d).


Self-reported medication use was compared cross-sectionally to running pace (m/s during usual run) in 25,552 male and 29,148 female National Runners’ Health Study participants.


The men ran a mean ± SD of 5.2 ± 3.1 km/d at 3.3 ± 0.5 m/s (8.3 ± 1.4 min/mile) and the women 4.7 ± 2.9 km/wk at 3.0 ± 0.4 m/s (9.2 ± 1.8 min/mile). When adjusted for kilometers per day, each meter-per second increment in intensity in men and women reduced the odds for antihypertensive drug use by 54% and 46%, respectively, reduced the odds for LDL-cholesterol–lowering medication use by 55% and 48%, respectively, and reduced the odds for antidiabetic medication use by 50% and 75%, respectively (all P < 0.0001). Compared with men who ran slower than 10 min/mile, the odds for medication use in those who ran or exceeded a 7-min/mile pace were 72% less for antihypertensive, 78% less for LDL-cholesterol lowering, and 67% less for antidiabetic medications (the corresponding odds reductions in women were 61%, 64%, and 87%, respectively, for 8 min/mile or faster versus slower than 11 min/mile). Although usual running pace correlated significantly with a 10-km performance (male, r = 0.55; females, r = 0.49), usual pace remained significantly related to lower use of all three medications in men and antihypertension and antidiabetic medications in women when adjusted for a 10-km performance.


Although these results do not prove causality, they show that exercise intensity is inversely associated with the prevalence of hypertension, hypercholesterolemia, and diabetes independent of exercise volume and cardiorespiratory fitness (10-km performance), suggesting that the more vigorous the exercise, the healthier the health benefits

lacing up